Cancun spring break can prove to be great one for couples and families seeking some quality time together. For some Cancun has also proved to be a therapeutic center as it provides some excellent treatment for people recovering from ailments.
Abbott announced today that the U.S. Food and Drug Administration has approved the company’s Absorb bioresorbable heart stent, making the first-of-its-kind medical device commercially available to treat people with coronary artery disease in the United States.
Absorb is the only fully dissolving stent approved for the treatment of coronary artery disease, which affects 15 million people in the United States and remains a leading cause of death worldwide, despite decades of therapeutic advances. While stents are traditionally made of metal, Abbott’s Absorb stent is made of a naturally dissolving material, similar to dissolving sutures. Absorb disappears completely in approximately three years, after it has done its job of keeping a clogged artery open and promoting healing of the treated artery segment. By contrast, metal stents are permanent implants that restrict vessel motion for the life of the person treated.
To view the multimedia release go to:
http://www.multivu.com/players/English/7826651-abbott-fda-approval-stent/
Ethicon* joins world-renowned experts in bariatric surgery to share the latest breakthroughs in science and innovation that are advancing surgery in the fight against obesity and metabolic diseases during ObesityWeek 2016, the combined annual meeting of the American Society for Metabolic & Bariatric Surgery (ASMBS) and The Obesity Society (TOS). Ethicon will highlight the growing body of research and evidence on the benefits of bariatric surgery, a new sleeve gastrectomy training module on the Touch Surgery app, and its comprehensive portfolio of bariatric surgery products aimed to improve patient outcomes.
“Ethicon’s mission is to lead the way in resolving the burden of obesity for both patients and healthcare systems by expanding access to care and demonstrating the critical value of treatment through research and evidence, while also enabling new technologies,” said Dr. Elliott Fegelman, Therapeutic Area Expert, Metabolics, Johnson & Johnson Innovation.
To view the multimedia release go to:
http://www.multivu.com/players/English/7965651-ethicon-bariatric-surgery-access-obesity-week-2016/
Countless women have said “Thank You Curél®” for relieving their dry skin. Now the Curél® Skincare team is giving people a whole new reason to say “Thanks”. This Thanksgiving, the experts behind Curél® Skincare are joining forces with lifestyle expert Katie Brown and Meals On Wheels Association of America to help care for friends, family, and those in need. From teaming up with Katie, to sharing smart holiday survival tips, Curél® Skincare is going beyond providing therapeutic skincare to supporting Meals On Wheels’ mission, which is to ensure that everyone has the comfort and care they deserve during the holidays. At a time when we all think about what we have to be thankful for, Curél® Skincare is giving everyone a reason to be thankful.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53289-katie-brown-teams-up-with-curel-skincare-support-meals-on-wheels
